论文信息 - Subchronic haloperidol treatment decreases the in vivo release of tachykinins in rat substantia nigra. - 字舞流文

Subchronic haloperidol treatment decreases the in vivo release of tachykinins in rat substantia nigra.

U. Ungerstedt | N. Lindefors | E. Brodin

[1] U. Ungerstedt,et al. Microdialysis combined with a sensitive radioimmunoassay. A technique for studying in vivo release of neuropeptides. , 1987, Journal of pharmacological methods.

[2] T. Bonner,et al. Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[3] U. Ungerstedt,et al. Neurokinin a and substance P in striato-nigral neurons in rat brain , 1986, Neuropeptides.

[4] T. Bonner,et al. Dopamine antagonist haloperidol decreases substance P, substance K, and preprotachykinin mRNAs in rat striatonigral neurons. , 1986, The Journal of biological chemistry.

[5] U. Ungerstedt,et al. Neuroleptic treatment induces region-specific changes in levels of neurokinin a and substance P in rat brain , 1986, Neuropeptides.

[6] A. Oblin,et al. Involvement of the D-2 dopamine receptor in the neuroleptic-induced decrease in nigral substance P. , 1984, European journal of pharmacology.

[7] G. Hanson,et al. Opposite responses in the striato-nigral substance P system to D1 and D2 receptor activation. , 1984, European journal of pharmacology.

[8] S. Nakanishi,et al. Nucleotide sequences of cloned cDNAs for two types of bovine brain substance P precursor , 1983, Nature.

[9] H. Y. Yang,et al. Substance P content of substantia nigra after chronic treatment with antischizophrenic drugs , 1978, Neuropharmacology.